Ventas (VTR) Projected to Post Quarterly Earnings on Thursday

Ventas (NYSE:VTR) is projected to release its Q4 2025 results after the market closes on Thursday, February 5th. Analysts expect the company to announce earnings of $0.89 per share and revenue of $1.5325 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 6, 2026 at 10:00 AM ET.

Ventas Trading Down 0.4%

Shares of Ventas stock opened at $77.33 on Tuesday. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 1.01. Ventas has a 12-month low of $58.72 and a 12-month high of $81.89. The company has a market capitalization of $36.32 billion, a price-to-earnings ratio of 148.71, a PEG ratio of 1.92 and a beta of 0.77. The firm’s 50-day moving average price is $78.17 and its two-hundred day moving average price is $72.92.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Wednesday, December 31st were issued a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Wednesday, December 31st. Ventas’s dividend payout ratio is 369.23%.

Insider Activity

In related news, CFO Robert F. Probst sold 29,930 shares of Ventas stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the sale, the chief financial officer directly owned 138,434 shares in the company, valued at $10,694,026.50. This trade represents a 17.78% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Peter J. Bulgarelli sold 2,229 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $80.08, for a total transaction of $178,498.32. Following the sale, the chief executive officer directly owned 106,488 shares in the company, valued at $8,527,559.04. The trade was a 2.05% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 140,727 shares of company stock valued at $10,901,338. 1.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Ventas

Several large investors have recently modified their holdings of the business. Wiser Advisor Group LLC bought a new stake in shares of Ventas in the third quarter worth $27,000. WFA of San Diego LLC acquired a new position in Ventas during the 2nd quarter worth about $73,000. Geneos Wealth Management Inc. lifted its holdings in Ventas by 39.4% during the 2nd quarter. Geneos Wealth Management Inc. now owns 1,323 shares of the real estate investment trust’s stock worth $84,000 after buying an additional 374 shares during the period. MUFG Securities EMEA plc bought a new stake in shares of Ventas in the 2nd quarter valued at about $84,000. Finally, Brown Brothers Harriman & Co. increased its stake in shares of Ventas by 202.7% in the third quarter. Brown Brothers Harriman & Co. now owns 1,550 shares of the real estate investment trust’s stock valued at $108,000 after buying an additional 1,038 shares during the period. Institutional investors own 94.18% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on VTR shares. Citigroup lifted their price objective on shares of Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research note on Tuesday, November 11th. KeyCorp raised their target price on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. The Goldman Sachs Group began coverage on Ventas in a report on Friday, January 9th. They set a “buy” rating and a $94.00 price target for the company. Scotiabank upped their price objective on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research report on Thursday, November 13th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $93.00 target price on shares of Ventas in a research report on Monday, December 15th. Fourteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $81.63.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.